NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 254 filers reported holding NATERA INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,049,819 | +1092.8% | 498,301 | +1211.7% | 0.01% | +600.0% |
Q2 2023 | $1,848,594 | -67.7% | 37,990 | -63.2% | 0.00% | -50.0% |
Q1 2023 | $5,730,386 | +106.5% | 103,213 | +49.4% | 0.00% | +100.0% |
Q4 2022 | $2,774,582 | +679.4% | 69,071 | +751.0% | 0.00% | – |
Q3 2022 | $356,000 | +4.4% | 8,116 | -15.7% | 0.00% | – |
Q2 2022 | $341,000 | -97.5% | 9,628 | -97.1% | 0.00% | -100.0% |
Q1 2022 | $13,629,000 | +52.5% | 335,031 | +250.2% | 0.00% | +33.3% |
Q4 2021 | $8,935,000 | +58.9% | 95,668 | +89.7% | 0.00% | 0.0% |
Q3 2021 | $5,622,000 | -54.4% | 50,441 | -53.6% | 0.00% | -40.0% |
Q2 2021 | $12,331,000 | +182.3% | 108,622 | +152.5% | 0.01% | +150.0% |
Q1 2021 | $4,368,000 | +77.6% | 43,022 | +74.1% | 0.00% | +100.0% |
Q4 2020 | $2,459,000 | -9.7% | 24,706 | -34.4% | 0.00% | 0.0% |
Q3 2020 | $2,722,000 | +573.8% | 37,676 | +365.8% | 0.00% | – |
Q2 2020 | $404,000 | +80.4% | 8,088 | +7.8% | 0.00% | – |
Q1 2020 | $224,000 | -58.7% | 7,502 | -54.6% | 0.00% | -100.0% |
Q3 2019 | $542,000 | +110.9% | 16,532 | +77.3% | 0.00% | – |
Q2 2019 | $257,000 | -17.9% | 9,325 | -43.8% | 0.00% | -100.0% |
Q2 2018 | $313,000 | – | 16,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |